RevenueNet IncomeP/EP/SEBITDividendStocksMarket capitalizationDebtLiabilitiesEquityAAQSEmployeesROEROAROCE
SciVision Biotech - Stock

SciVision Biotech Debt 2024

SciVision Biotech Debt

-163.19 TWD

Ticker

1786.TW

ISIN

TW0001786002

In 2024, SciVision Biotech's total debt was -163.19 TWD, a -6.77% change from the -175.03 TWD total debt recorded in the previous year.

SciVision Biotech Aktienanalyse

What does SciVision Biotech do?

SciVision Biotech ist eines der beliebtesten Unternehmen auf Eulerpool.com.

Debt Details

Understanding SciVision Biotech's Debt Structure

SciVision Biotech's total debt refers to the cumulative financial obligations the company owes to external parties. This can include short-term and long-term borrowings, bonds, loans, and other financial instruments. Assessing the company's debt levels is crucial for evaluating its financial health, risk profile, and ability to fund operations and expansions.

Year-to-Year Comparison

Analyzing SciVision Biotech's debt structure over the years provides insights into the firm’s financial strategy and stability. A reduction in debt can indicate financial strength and operational efficiency, while an increase may signal growth investments or potential financial challenges ahead.

Impact on Investments

Investors pay close attention to SciVision Biotech’s debt levels as they can influence the company’s risk and return profiles. Excessive debt can lead to financial strain, while moderate and well-managed debt can be a catalyst for growth and expansion, making it a critical aspect of investment evaluations.

Interpreting Debt Fluctuations

Shifts in SciVision Biotech’s debt levels can be attributed to various operational and strategic factors. An increase in debt might be geared towards funding expansion projects or enhancing operational capacity, while a decrease may indicate profit realizations or an approach to minimize financial risk and leverage.

Frequently Asked Questions about SciVision Biotech Stock

What is the debt of SciVision Biotech this year?

SciVision Biotech has a debt level of -163.19 TWD this year.

What was the debt of SciVision Biotech compared to the previous year?

The debt of SciVision Biotech has increased by -6.77% compared to the previous year dropped.

What are the consequences of high debt for investors in SciVision Biotech?

High debt can pose a risk for investors of SciVision Biotech, as it can weaken the company's financial position and hinder its ability to fulfill its obligations.

What are the consequences of low debt for investors of SciVision Biotech?

Low debt means that SciVision Biotech has a strong financial position and is able to fulfill its obligations without overburdening its finances.

How does an increase in debt from SciVision Biotech affect the company?

An increase in debt of SciVision Biotech can adversely affect the financial condition of the company and result in a higher burden on its finances.

How does a reduction of debt of SciVision Biotech affect the company?

A reduction in debt of SciVision Biotech can strengthen the company's financial position and improve its ability to meet its financial obligations.

What are some factors that influence the debt of SciVision Biotech?

Some factors that can influence the debt of SciVision Biotech include investments, acquisitions, operating costs, and revenue development.

Why are the debts of SciVision Biotech so important for investors?

The debts of SciVision Biotech are important for investors as they serve as an indicator of the company's financial stability. It provides investors with information on how the company fulfills its financial obligations.

What strategic measures can SciVision Biotech take to change the debt?

To change the debt, SciVision Biotech can take measures such as cost savings, increasing revenue, selling assets, making investments, or forming partnerships. It is important for the company to conduct a thorough review of its financial situation to determine the best strategic actions to change its debt.

How much dividend does SciVision Biotech pay?

Over the past 12 months, SciVision Biotech paid a dividend of 1.98 TWD . This corresponds to a dividend yield of about 1.49 %. For the coming 12 months, SciVision Biotech is expected to pay a dividend of 2.04 TWD.

What is the dividend yield of SciVision Biotech?

The current dividend yield of SciVision Biotech is 1.49 %.

When does SciVision Biotech pay dividends?

SciVision Biotech pays a quarterly dividend. This is distributed in the months of October, November, August, August.

How secure is the dividend of SciVision Biotech?

SciVision Biotech paid dividends every year for the past 8 years.

What is the dividend of SciVision Biotech?

For the upcoming 12 months, dividends amounting to 2.04 TWD are expected. This corresponds to a dividend yield of 1.53 %.

In which sector is SciVision Biotech located?

SciVision Biotech is assigned to the 'Health' sector.

Wann musste ich die Aktien von SciVision Biotech kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of SciVision Biotech from 8/18/2023 amounting to 1.98 TWD, you needed to have the stock in your portfolio before the ex-date on 7/26/2023.

When did SciVision Biotech pay the last dividend?

The last dividend was paid out on 8/18/2023.

What was the dividend of SciVision Biotech in the year 2023?

In the year 2023, SciVision Biotech distributed 1.418 TWD as dividends.

In which currency does SciVision Biotech pay out the dividend?

The dividends of SciVision Biotech are distributed in TWD.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

Andere Kennzahlen von SciVision Biotech

Our stock analysis for SciVision Biotech Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of SciVision Biotech Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.